United States, Texas — Sugar Land, Texas

United States, Texas is a clinical research site located in Sugar Land, Texas, United States 77479.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

United States, Texas has participated in 1 clinical trials.

Therapeutic areas: Crohn's Disease.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Sugar Land

Browse all research sites in Texas · View every site in Sugar Land

• Memorial Hermann Surgical Hospital First Colony
• Memorial Hermann Sugar Land Hospital
• The University of Texas, MD Anderson Cancer Center - Sugar Land
• Houston Methodist Hospital - Sugarland
• Houston Methodist Sugar Land Hospital
• Houston Methodist Hospital Sugar Land
• 8401176 - Methodist Sugar Land Hospital
• Memorial Hermann Community Hospitals
• MD Anderson in Sugar Land
• Novo Nordisk Investigational Site
• Texas Oncology Cancer Center Sugar Land
• Research Site

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States, Texas?

United States, Texas has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States, Texas conducted?

United States, Texas has 1 clinical trials on record. Their work covers Crohn's Disease.

Is United States, Texas accredited by Crixeo Clinical Trials?

United States, Texas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about United States, Texas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.